Virtu Financial LLC Spero Therapeutics, Inc. Transaction History

Virtu Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 20, 2024	BUY	$1.35 - $1.79 $24,543 - $32,542	18,180 New	18,180 $31,000
Q2 2023 Jul 27, 2023	BUY	$1.42 - $1.95 $31,516 - $43,280	22,195 New	22,195 $32,000
Q4 2022 Feb 15, 2023	BUY	$1.55 - $2.12 $53,271 - $72,862	34,369 New	34,369 $59,000
Q2 2019 Aug 13, 2019	SELL	$10.25 - $14.36 $107,266 - $150,277	-10,465 Closed	0 $0
Q1 2019 Apr 12, 2019	BUY	$6.26 - $13.31 $65,510 - $139,289	10,465 New	10,465 $134,000

13.9M

200

200

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $33.3M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.